Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 87,020 shares at $21.23 ($1.8M) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Open-market purchase of $1.8M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.57 | 37,911 | $780K | 43.4% |
| 2 | $20.57 | 37,911 | $780K | 43.4% |
| 3 | $21.23 | 2,489 | $53K | 2.9% |
| 4 | $21.23 | 2,489 | $53K | 2.9% |
| 5 | $20.93 | 3,110 | $65K | 3.6% |
| 6 | $20.93 | 3,110 |
| $65K |
| 3.6% |
| Total | $20.63 avg | 87,020 | $1.8M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |